Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
- PMID: 16907966
- PMCID: PMC1562443
- DOI: 10.1186/1477-5751-5-11
Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
Abstract
Background: Soy isoflavones show structural and functional similarities to estradiol. Available data indicate that estradiol and estradiol-like components may interact with gut "satiety hormones" such as peptide YY (PYY) and ghrelin, and thus influence body weight. In a randomized, double-blind, placebo-controlled, cross-over trial with 34 healthy postmenopausal women (59 +/- 6 years, BMI: 24.7 +/- 2.8 kg/m2), isoflavone-enriched cereal bars (50 mg isoflavones/day; genistein to daidzein ratio 2:1) or non-isoflavone-enriched control bars were consumed for 8 weeks (wash-out period: 8-weeks). Seventeen of the subjects were classified as equol producers. Plasma concentrations of ghrelin and PYY, as well as energy intake and body weight were measured at baseline and after four and eight weeks of each intervention arm.
Results: Body weight increased in both treatment periods (isoflavone: 0.40 +/- 0.94 kg, P < 0.001; placebo: 0.66 +/- 0.87 kg, P = 0.018), with no significant difference between treatments. No significant differences in energy intake were observed (P = 0.634). PYY significantly increased during isoflavone treatment (51 +/- 2 pmol/L vs. 55 +/- 2 pmol/L), but not during placebo (52 +/- 3 pmol/L vs. 50 +/- 2 pmol/L), (P = 0.010 for treatment differences, independent of equol production). Baseline plasma ghrelin was significantly lower in equol producers (110 +/- 16 pmol/L) than in equol non-producers (162 +/- 17 pmol/L; P = 0.025).
Conclusion: Soy isoflavone supplementation for eight weeks did not significantly reduce energy intake or body weight, even though plasma PYY increased during isoflavone treatment. Ghrelin remained unaffected by isoflavone treatment. A larger and more rigorous appetite experiment might detect smaller differences in energy intake after isoflavone consumption. However, the results of the present study do not indicate that increased PYY has a major role in the regulation of body weight, at least in healthy postmenopausal women.
Similar articles
-
Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation.Climacteric. 2007 Dec;10(6):471-9. doi: 10.1080/13697130701624971. Climacteric. 2007. PMID: 18049940 Clinical Trial.
-
One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.Eur J Clin Nutr. 2006 Sep;60(9):1039-45. doi: 10.1038/sj.ejcn.1602415. Epub 2006 Feb 15. Eur J Clin Nutr. 2006. PMID: 16482068
-
Altered ghrelin and peptide YY responses to meals in bulimia nervosa.Clin Endocrinol (Oxf). 2005 Jan;62(1):74-8. doi: 10.1111/j.1365-2265.2004.02176.x. Clin Endocrinol (Oxf). 2005. PMID: 15638873
-
Effect of soy isoflavones on circulating C-reactive protein in postmenopausal women: meta-analysis of randomized controlled trials.Menopause. 2011 Nov;18(11):1256-62. doi: 10.1097/gme.0b013e31821bfa24. Menopause. 2011. PMID: 21712733 Review.
-
Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants.Am J Physiol Endocrinol Metab. 2010 May;298(5):E909-19. doi: 10.1152/ajpendo.00191.2009. Epub 2010 Feb 23. Am J Physiol Endocrinol Metab. 2010. PMID: 20179246 Review.
Cited by
-
Acute selective bioactivity of grape seed proanthocyanidins on enteroendocrine secretions in the gastrointestinal tract.Food Nutr Res. 2017 Jun 7;61(1):1321347. doi: 10.1080/16546628.2017.1321347. eCollection 2017. Food Nutr Res. 2017. PMID: 28659730 Free PMC article.
-
Appetitive hormones, but not isoflavone tablets, influence overall and central adiposity in healthy postmenopausal women.Menopause. 2010 May-Jun;17(3):594-601. doi: 10.1097/gme.0b013e3181c92134. Menopause. 2010. PMID: 20142790 Free PMC article. Clinical Trial.
-
Effect of Soy and Soy Isoflavones on Obesity-Related Anthropometric Measures: A Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials.Adv Nutr. 2017 Sep 15;8(5):705-717. doi: 10.3945/an.117.015370. Print 2017 Sep. Adv Nutr. 2017. PMID: 28916571 Free PMC article.
-
The Association of Serum Total Peptide YY (PYY) with Obesity and Body Fat Measures in the CODING Study.PLoS One. 2014 Apr 17;9(4):e95235. doi: 10.1371/journal.pone.0095235. eCollection 2014. PLoS One. 2014. PMID: 24743402 Free PMC article. Clinical Trial.
-
Soy intake is related to a lower body mass index in adult women.Eur J Nutr. 2008 Apr;47(3):138-44. doi: 10.1007/s00394-008-0707-x. Epub 2008 Apr 22. Eur J Nutr. 2008. PMID: 18427855 Free PMC article.
References
-
- Bosello O, Cominacini L, Zocca I, Garbin U, Compri R, Davoli A, Brunetti L. Short- and long-term effects of hypocaloric diets containing proteins of different sources on plasma lipids and apoproteins of obese subjects. Ann Nutr Metab. 1988;32:206–214. - PubMed
-
- Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr. 2001;131:1202–1206. - PubMed
-
- Halton TL, Hu FB. The effects of high protein diets on thermogenesis, satiety and weight loss: a critical review. J Am Coll Nutr. 2004;23:373–385. - PubMed
-
- Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr. 2002;76:1191–1201. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical